Then, the expression levels of GSDMD were detected and the results showed significantly lower expression in U87 and A172 glioma cells treated with si-GSDMD (Figure 8A, Supplementary Figure S5A), which was also confirmed by the WB assay (Figure 8B). Here, GSDMD is linked to central nervous system cancer.